日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Outcomes and Subsequent Treatment Patterns in Patients with Advanced Non-Small Cell Lung Cancer and Atypical EGFR Mutations Receiving First-Line Osimertinib Monotherapy

接受一线奥希替尼单药治疗的晚期非小细胞肺癌伴非典型EGFR突变患者的真实世界疗效及后续治疗模式

Nieva, Jorge J; Wang, Xuejun; Doroshow, Deborah; Servidio, Leslie; Cooper, Miranda; Lau, Yan Kwan; Karia, Pritesh S; Robichaux, Jacqulyne

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer

EGFR突变型IB-IIIA期非小细胞肺癌切除术后辅助奥希替尼治疗的分子残留病灶分析

Herbst, Roy S; John, Thomas; Grohé, Christian; Goldman, Jonathan W; Kato, Terufumi; Laktionov, Konstantin; Bonanno, Laura; Tiseo, Marcello; Majem, Margarita; Dómine, Manuel; Ahn, Myung-Ju; Kowalski, Dariusz M; Pérol, Maurice; Sriuranpong, Virote; Özgüroğlu, Mustafa; Bhetariya, Preetida; Markovets, Aleksandra; Rukazenkov, Yuri; Muldoon, Caitlin; Robichaux, Jacqulyne; Hartmaier, Ryan; Tsuboi, Masahiro; Wu, Yi-Long

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

波齐替尼治疗EGFR 20号外显子插入突变型非小细胞肺癌:II期ZENITH试验的临床疗效及EGFR 20号外显子插入位置对药物敏感性的差异性影响

Le, Xiuning; Robichaux, Jacqulyne P; Nilsson, Monique; Vijayan, R S K; Ravichandran, Ashwin; Wu, Jia; Elamin, Yasir Y; Hong, Lingzhi; Pei, Jun; He, Jun; Patel, Sonia; Udagawa, Hibiki; Mani, Sriramvignesh; Jang, Chang Woon; Clarke, Jeffrey M; Tchekmedyian, Nishan; Goldman, Jonathan W; Socinski, Mark; Bhat, Gajanan; Leu, Sharon; Bunn, Veronica; Su, Zhenqiang; Vincent, Sylvie; Lawson, John W; Cross, Jason B; Heymach, John V

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

HER4 和 EGFR 激活 NRG1 融合驱动癌症中的细胞信号传导:对 HER2-HER3 特异性靶向与泛 HER 靶向策略的启示

Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

CD70是EMT相关EGFR酪氨酸激酶抑制剂耐药中上调的治疗靶点。

Monique B Nilsson ,Yan Yang ,Simon Heeke ,Sonia A Patel ,Alissa Poteete ,Hibiki Udagawa ,Yasir Y Elamin ,Cesar A Moran ,Yukie Kashima ,Thiruvengadam Arumugam ,Xiaoxing Yu ,Xiaoyang Ren ,Lixia Diao ,Li Shen ,Qi Wang ,Minying Zhang ,Jacqulyne P Robichaux ,Chunhua Shi ,Allyson N Pfeil ,Hai Tran ,Don L Gibbons ,Jason Bock ,Jing Wang ,John D Minna ,Susumu S Kobayashi ,Xiuning Le ,John V Heymach

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

波齐替尼治疗EGFR 20号外显子突变型非小细胞肺癌:临床疗效、耐药机制及插入位点对药物敏感性的影响

Yasir Y Elamin ,Jacqulyne P Robichaux ,Brett W Carter ,Mehmet Altan ,Hai Tran ,Don L Gibbons ,Simon Heeke ,Frank V Fossella ,Vincent K Lam ,Xiuning Le ,Marcelo V Negrao ,Monique B Nilsson ,Anisha Patel ,R S K Vijayan ,Jason B Cross ,Jianjun Zhang ,Lauren A Byers ,Charles Lu ,Tina Cascone ,Lei Feng ,Rajyalakshmi Luthra ,Francis A San Lucas ,Geeta Mantha ,Mark Routbort ,George Blumenschein Jr ,Anne S Tsao ,John V Heymach

Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial

泊齐替尼治疗HER2 20号外显子突变型非小细胞肺癌患者:一项II期试验的结果

Elamin, Yasir Y; Robichaux, Jacqulyne P; Carter, Brett W; Altan, Mehmet; Gibbons, Don L; Fossella, Frank V; Lam, Vincent K; Patel, Anisha B; Negrao, Marcelo V; Le, Xiuning; Mott, Frank E; Zhang, Jianjun; Feng, Lei; Blumenschein, George Jr; Tsao, Anne S; Heymach, John V

Structure-based classification predicts drug response in EGFR-mutant NSCLC

基于结构的分类预测EGFR突变型非小细胞肺癌的药物反应

Robichaux, Jacqulyne P; Le, Xiuning; Vijayan, R S K; Hicks, J Kevin; Heeke, Simon; Elamin, Yasir Y; Lin, Heather Y; Udagawa, Hibiki; Skoulidis, Ferdinandos; Tran, Hai; Varghese, Susan; He, Junqin; Zhang, Fahao; Nilsson, Monique B; Hu, Lemei; Poteete, Alissa; Rinsurongkawong, Waree; Zhang, Xiaoshan; Ren, Chenghui; Liu, Xiaoke; Hong, Lingzhi; Zhang, Jianjun; Diao, Lixia; Madison, Russell; Schrock, Alexa B; Saam, Jennifer; Raymond, Victoria; Fang, Bingliang; Wang, Jing; Ha, Min Jin; Cross, Jason B; Gray, Jhanelle E; Heymach, John V

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

EGFR突变型非小细胞肺癌免疫图谱分析揭示CD73/腺苷通路是潜在的治疗靶点

Xiuning Le ,Marcelo V Negrao ,Alexandre Reuben ,Lorenzo Federico ,Lixia Diao ,Daniel McGrail ,Monique Nilsson ,Jacqulyne Robichaux ,Irene Guijarro Munoz ,Sonia Patel ,Yasir Elamin ,You-Hong Fan ,Won-Chul Lee ,Edwin Parra ,Luisa Maren Solis Soto ,Runzhe Chen ,Jun Li ,Tatiana Karpinets ,Roohussaba Khairullah ,Humam Kadara ,Carmen Behrens ,Boris Sepesi ,Ruiping Wang ,Mingrui Zhu ,Linghua Wang ,Ara Vaporciyan ,Jack Roth ,Stephen Swisher ,Cara Haymaker ,Jianhua Zhang ,Jing Wang ,Kwok-Kin Wong ,Lauren A Byers ,Chantale Bernatchez ,Jianjun Zhang ,Ignacio I Wistuba ,Don L Gibbons ,Esra A Akbay ,John V Heymach

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype

EGFR突变型非小细胞肺癌中HIF-1α调控的改变:对血管内皮生长因子依赖性表型的意义

Nilsson, Monique B; Robichaux, Jacqulyne; Herynk, Matthew H; Cascone, Tina; Le, Xiuning; Elamin, Yasir; Patel, Sonia; Zhang, Fahao; Xu, Li; Hu, Limei; Diao, Lixia; Shen, Li; He, Junqin; Yu, Xiaoxing; Nikolinakos, Petros; Saintigny, Pierre; Fang, Bingliang; Girard, Luc; Wang, Jing; Minna, John D; Wistuba, Ignacio I; Heymach, John V